Brücher BLDM - Search Results

1

VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus.

Möbius C, Freire J, Becker I, Feith M, Brücher BLDM, Hennig M, Siewert JR, Stein HJ. Möbius C, et al. Among authors: brucher bldm. World J Surg. 2007 Sep;31(9):1768-1772. doi: 10.1007/s00268-006-0373-1. World J Surg. 2007. PMID: 17354029

2

Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine.

von Rahden BH, Brücher BL, Langner C, Siewert JR, Stein HJ, Sarbia M. von Rahden BH, et al. Br J Surg. 2006 Nov;93(11):1424-32. doi: 10.1002/bjs.5426. Br J Surg. 2006. PMID: 17022010

3

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography.

Brücher BL, Weber W, Bauer M, Fink U, Avril N, Stein HJ, Werner M, Zimmerman F, Siewert JR, Schwaiger M. Brücher BL, et al. Ann Surg. 2001 Mar;233(3):300-9. doi: 10.1097/00000658-200103000-00002. Ann Surg. 2001. PMID: 11224616 Free PMC article.

4

Achalasia and esophageal cancer: incidence, prevalence, and prognosis.

Brücher BL, Stein HJ, Bartels H, Feussner H, Siewert JR. Brücher BL, et al. World J Surg. 2001 Jun;25(6):745-9. doi: 10.1007/s00268-001-0026-3. World J Surg. 2001. PMID: 11376410

5

Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma.

Brücher BL, Stein HJ, Werner M, Siewert JR. Brücher BL, et al. Cancer. 2001 Oct 15;92(8):2228-33. doi: 10.1002/1097-0142(20011015)92:8<2228::aid-cncr1567>3.0.co;2-4. Cancer. 2001. PMID: 11596042

6

Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial.

Brücher BL, Stein HJ, Zimmermann F, Werner M, Sarbia M, Busch R, Dittler HJ, Molls M, Fink U, Siewert JR. Brücher BL, et al. Eur J Surg Oncol. 2004 Nov;30(9):963-71. doi: 10.1016/j.ejso.2004.06.008. Eur J Surg Oncol. 2004. PMID: 15498642 Clinical Trial.

7

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment.

Wieder HA, Brücher BL, Zimmermann F, Becker K, Lordick F, Beer A, Schwaiger M, Fink U, Siewert JR, Stein HJ, Weber WA. Wieder HA, et al. J Clin Oncol. 2004 Mar 1;22(5):900-8. doi: 10.1200/JCO.2004.07.122. J Clin Oncol. 2004. PMID: 14990646

8

The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.

Brücher BL, Becker K, Lordick F, Fink U, Sarbia M, Stein H, Busch R, Zimmermann F, Molls M, Höfler H, Siewert JR. Brücher BL, et al. Cancer. 2006 May 15;106(10):2119-27. doi: 10.1002/cncr.21850. Cancer. 2006. PMID: 16607651 Free article.

9

Prognostic factors in resected primary small bowel tumors.

Brücher BL, Roder JD, Fink U, Stein HJ, Busch R, Siewert JR. Brücher BL, et al. Dig Surg. 1998;15(1):42-51. doi: 10.1159/000018585. Dig Surg. 1998. PMID: 9845562 Review.

10

[Esophagus carcinoma--systemic or local risk of recurrence--which perioperative measures are successful?].

Siewert JR, Brücher BL, Stein HJ, Fink U. Siewert JR, et al. Langenbecks Arch Chir Suppl Kongressbd. 1998;115:290-4. Langenbecks Arch Chir Suppl Kongressbd. 1998. PMID: 9931627 Clinical Trial. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters